Radek Kaczmarek 's Avatar

Radek Kaczmarek

@rkaczmarekdr.bsky.social

26 Followers  |  44 Following  |  3 Posts  |  Joined: 15.11.2024  |  1.4059

Latest posts by rkaczmarekdr.bsky.social on Bluesky

Thank you for the kind words.

26.06.2025 16:24 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Last day starts with an
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?

25.06.2025 13:18 β€” πŸ‘ 6    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0
Preview
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry Information on inhibitor development in nonsevere hemophilia and its association with clotting factor concentrate type is limited.

What percentage of hemophilia patients develop inhibitors?

New data from the European Haemophilia Safety Surveillance Inhibitor reveals inhibitor rates of
Hemophilia A: 4.2 per 1000 treatment years
Hemophilia B: 0.1 per 1000 treatment years

Read more here: www.rpthjournal.org/article/S247...

16.06.2025 18:30 β€” πŸ‘ 2    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Preview
Glycoproteins, Glycolipids, or Both: Why do Glycosyltransferases Recognize Different Acceptors? Glycosylation is an important post-translational modification catalyzed by glycosyltransferases (GTs), which comprise a large group of enzymes with diversified specificity. Most GTs show high specifi...

Nice #glycotime review that pulls together the emerging story of glycosyltransferase specificity for cellular substrates

chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/...

07.05.2025 11:42 β€” πŸ‘ 48    πŸ” 16    πŸ’¬ 1    πŸ“Œ 0
Post image Post image Post image Post image

Specificity in glycosylation! Have you ever wondered why some glycosyltransferases recognize glycoproteins, some glycolipids, and some both? Together with @kmikolajczyk.bsky.social and @rkaczmarekdr.bsky.social, we try to answer that complicated question.

#glycotime
tinyurl.com/5b6kxhp3

07.05.2025 09:13 β€” πŸ‘ 25    πŸ” 14    πŸ’¬ 0    πŸ“Œ 0

It is essential for #genetherapy progress for unsuccessful clinicals trials to be published. We discuss recent study showing no benefit for prophylactic steroids after #AAV for #hemophilia.

authors.elsevier.com/a/1k-re5TuFx...

w/ @rkaczmarekdr.bsky.social

30.04.2025 17:41 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Comprehensive review of gene therapy in #hemophilia accepted for publication by Molecular Therapy. The pre-proof is on line at tinyurl.com/3sb4nuex

31.03.2025 20:54 β€” πŸ‘ 4    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

Our paper on inhibitor trends is now published in the journal Haemophilia. The number of inhibitors in previously untreated patients has markedly reduced, but it is possible that this is due to delayed exposure to FVIII. tinyurl.com/2mr3t5e3

03.04.2025 19:21 β€” πŸ‘ 8    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Thank you @czerwinsmarcin.bsky.social!

30.03.2025 21:31 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

I was pleased to moderate the session on basic and translational research in coagulation and fibrinolysis with Dr. Carlos Bravo-Perez at #ASH2024 earlier today.

Six excellent presentations are now available on the Virtual Platform.

08.12.2024 21:57 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 2    πŸ“Œ 0

@rkaczmarekdr is following 20 prominent accounts